| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/13/2006 | US7060818 Synthesis of macrocyclic tetraamido compounds and new metal insertion process |
| 06/13/2006 | US7060817 Sulfonamide anions as catalysts for NCO oligomerization |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060704 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders |
| 06/13/2006 | US7060427 Anthraquinone and its derivatives |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2005107464A3 Compounds and compositions as cathepsin s inhibitors |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122388 Thiocarbamate inhibitors of alpha-4 integrins |
| 06/08/2006 | US20060122386 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122243 Antiallergic |
| 06/08/2006 | US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 06/08/2006 | US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells |
| 06/08/2006 | DE102004029797A1 Mittel zum Färben von keratinhaltigen Fasern Formulations for coloring keratin-containing fibers |
| 06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
| 06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
| 06/07/2006 | EP1664009A1 Preparation method for quetiapine |
| 06/07/2006 | EP1664008A1 Process for the preparation of amorphous form of repaglinide |
| 06/07/2006 | EP1664007A1 Preparation of quetiapine |
| 06/07/2006 | EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663934A1 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds |
| 06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7057040 Substituted aryl alkenoic acid heterocyclic amides |
| 06/06/2006 | US7056922 Acylamino cyclopropane derivatives |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 06/01/2006 | WO2006056448A1 CRYSTALLINE MODIFICATIONS OF N-α-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-3-HYDROXYAMIDINO-(L)-PHENYLALANINE-4-ETHOXYCARBONYLPIPERAZIDE AND/OR SALTS THEREOF |
| 06/01/2006 | WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | US20060116354 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon |
| 06/01/2006 | DE102004057195A1 Kristalline Modifikationen von Crystalline modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon and / or salts thereof |
| 06/01/2006 | CA2581959A1 Crystalline modifications of n-.alpha.-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(l)-phenylalanine-4-ethoxycarbonylpiperazide and/or salts thereof |
| 05/31/2006 | EP1661900A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
| 05/31/2006 | EP1660472A1 Aryl piperidine amides |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1660470A1 Piperazine-based sensitisers |
| 05/31/2006 | EP1660469A1 Process for the preparation of 11-(1-piperazinyl)dibenzo 'b, f! '1 ,4!-thiazepine, an intermediate in the synthesis of the antipsychotic drug quetiapine |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660439A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 05/31/2006 | EP1660436A1 Cathepsin inhibitors |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660137A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1401821A4 Novel phenylalkyl diamine and amide analogs |
| 05/31/2006 | EP1341743B1 Organic reactions with co generating materials |
| 05/31/2006 | CN1257896C Functional molecule material containing four tertiary amine branches and preparation method |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053087 Aminocycloalkyl cinnamide compounds for arrhythmia and analgesics and anesthetics |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006034446A3 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | CA2574535A1 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use |
| 05/25/2006 | US20060111533 Cationic polymer; detergents, cleaning compounds |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111352 Acetylenic compounds useful in treating inflammatory disorders |
| 05/25/2006 | US20060111336 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance |
| 05/25/2006 | US20060110743 Drug evolution: drug design at hot spots |
| 05/24/2006 | EP1659113A1 Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
| 05/24/2006 | EP1658277A1 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
| 05/24/2006 | EP1658276A1 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 05/24/2006 | EP1658267A2 Inhibitors of cathepsin s |
| 05/24/2006 | EP1658264A2 Methods and compositions for treating amyloid-related diseases |
| 05/24/2006 | EP1658077A2 Dual function compounds and uses thereof |
| 05/24/2006 | EP1658066A2 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 05/24/2006 | EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors |
| 05/24/2006 | EP1370526B1 Diamides which inhibit tryptase and factor xa activity |
| 05/24/2006 | CN1777583A Methods for producing cyclic benzamidine derivatives |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1257163C Method for synthesizing 1-acetyl-4-(4-hydroxy phenyl) piperazine |
| 05/23/2006 | US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | CA2301189C Non-steroidal ligands for the estrogen receptor |
| 05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
| 05/18/2006 | WO2006051808A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 05/18/2006 | WO2006051772A1 Liquid electrolyte |
| 05/18/2006 | WO2006051489A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 05/18/2006 | WO2006051378A1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
| 05/18/2006 | WO2006051314A2 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | WO2006050909A1 Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them |
| 05/18/2006 | WO2006050908A1 Inhibitors of 11βετα-hydroxy steroid dehydrogenase type 1 (11beta-hsd1) |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile |
| 05/18/2006 | US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's |
| 05/18/2006 | US20060106018 treating or ameliorating a reactive oxygen species mediated inflammatory disorder as interleukin-2 mediated disorder, inflammatory arthritis, Alzheimer's disease; inhibitors of nicotinamide adenine dinucleotide oxidase; N1-[2-[4-[(4-chlorophenyl)ethynyl]phenoxy]ethyl]-N4-propyl-1,4-benzenedimethanamine |